“…In some studies, acceptable production yield was achieved using artificial genes with optimized codon usage encoding thaumatin II (Weickmann et al, 2004, Daniell et al, 2000, but the recombinant protein was obtained as insoluble inclusion bodies, thereby requiring a renaturation procedure using a reduced/oxidized glutathione system to obtain a soluble, correctly folded, and active thaumatin II. Another expression system using Aspergillus awamori has been attempted to satisfy the expression yield of recombinant thaumatin, but three forms of recombinant thaumatin that differ in one amino acid at the N-terminus were obtained, resulting in a non-homogeneous product (Moralejo et al, 1999, Lombraña et al, 2004.…”